Cleveland Clinic

WASHINGTON — In an exploratory analysis of the PROTECTED TAVR trial of patients undergoing transcatheter aortic valve replacement, cerebral embolic protection reduced risk for short-term stroke in patients from the U.S. but not elsewhere.

It’s that time of year again.

This month’s cover story is both enlightening and distressing.

Billing for electronic messages through the patient portal can cause confusion and create communication barriers between clinicians and patients, according to study results.

A new consensus statement from the Heart Failure Society of America outlines how device-based therapies can help certain patients with HF and how HF devices can be integrated into clinical workflow.

Prior SARS-CoV-2 infection, especially for those requiring hospitalization, was associated with increased risk for heart attack and stroke for up to 3 years, even among people with no history of heart disease, researchers reported.

The timing with which patients with newly diagnosed multiple myeloma began treatment with oral antimyeloma medications varied greatly by age and race, according to retrospective study results.

SAN DIEGO — Although a flood of COVID-19 and long COVID research continues to emerge, concerns may be limited for rheumatologists, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

SAN DIEGO — Diagnosing giant cell arteritis and polymyalgia rheumatica can “fascinate” and cause “trepidation” in equal measure due to their similarities and complications, said a speaker at the 2024 Congress of Clinical Rheumatology West.

Adults with primary aldosteronism had improvements in disease severity after undergoing an adrenalectomy, according to findings published in Endocrine Practice.